Cornelis Vlaar

Professor

University of Puerto Rico, Medical Sciences Campus

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Cornelis Vlaar is a Professor at the University of Puerto Rico, Medical Sciences Campus, in the United States. His research focuses on pharmaceutical manufacturing processes, including crystallization and flow synthesis. Notable recent work includes studies on precision medicine, drug efficacy in cancer therapies, and solubility measurements in various solvent mixtures.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Mariana Cooke

University of Pennsylvania

UNITED STATES

View details

Rodolfo Romanach

Professor

University of Puerto Rico-Mayaguez

UNITED STATES

View details

Stephanie Dorta-Estremera

Assistant Professor

University of Puerto Rico, Medical Sciences Campus

UNITED STATES

View details

Lilia Kucheryavykh

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cornelis Vlaar

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Controlled API crystallization during additive manufacturing of solid dosage form for flexible integrated pharmaceutical manufacturing

VAV2 Drives EGFR-Mediated Rac1 Responses in Prostate Cancer

Continuous Flow Synthesis of Nitrofuran Pharmaceuticals Using Acetyl Nitrate

A review of precision medicine in developing pharmaceutical products: Perspectives and opportunities

Measurements and Correlation of Timolol Maleate Solubility in Biobased Neat and Binary Solvent Mixtures

Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer

Continuous Flow Intensification for the Synthesis of High-Purity Warfarin

Solubility Measurements and Correlation of Modafinil in Neat Solvents and Binary Solvent Mixtures

Continuous flow synthesis and crystallization of modafinil: a novel approach for integrated manufacturing

The Rac inhibitor HV-107 as a potential therapeutic for metastatic breast cancer

Characterization of Novel Derivatives of MBQ-167, an Inhibitor of the GTP-binding Proteins Rac/Cdc42

Out-smarting smart drug modafinil through flow chemistry

Efficacy of Rac and Cdc42 inhibitor MBQ-167 in triple negative breast cancer

Polymorphism in early development: The account of MBQ-167

Solubility Measurements and Correlation of MBQ-167 in Neat and Binary Solvent Mixtures

Genotype-driven pharmacokinetic simulations of warfarin levels in Puerto Ricans

Collaborators (4)

Mariana Cooke

Rodolfo Romanach

Stephanie Dorta-Estremera

Lilia Kucheryavykh

Make your next move.